Sirona Dental, Inc.

Sirona Dental, Inc., a Charlotte, North Carolina-based subsidiary of Dentsply Sirona Inc., supplies advanced dental equipment and consumables to the Department of Defense and Veterans Affairs healthcare facilities exclusively as a delivery-order recipient under its parent company's prime indefinite-delivery contracts. The company operates as a large-scale manufacturer without set-aside designations and receives no direct prime awards; all federal business flows through parent-company delivery orders issued by the Defense Logistics Agency and other federal healthcare customers.

Sirona Dental's product portfolio encompasses digital scanning and milling systems (CEREC PrimeScan AC, CEREC PRIMEMILL US, CEREC Speedfire), dental imaging equipment (XIOS Plus sensors), dental burs and cutting instruments, disposable sleeves and cleaning materials, implant components (titanium bases, abutment screws), restorative materials, and operator training services. Representative recent work includes a $89,593 delivery order from the Defense Health Agency (October 31, 2025) for a CEREC PrimeScan AC TP Steel scanning system, multiple CEREC PRIMEMILL US milling equipment orders valued at $49,996.45 each issued by the Defense Logistics Agency Medical Supply Chain (September–October 2025), and consumable supply deliveries ranging from $23 for filter units to $7,310.67 for SCANPOST restorative material kits, all issued by DLA Medical Supply Chain.

Customer concentration is extreme and reflects the subsidiary's operational structure. The Defense Logistics Agency Troop Support Medical accounts for 16,368 awards (99% of the 16,640 total awards in the portfolio) and $166.6 million in combined potential value (75% of the $221.6 million total). Secondary customers—the Department of the Navy Bureau of Medicine and Surgery, the Department of the Army Medical Command, the Defense Health Agency, and the Veterans Health Administration—collectively account for less than 1% of awards and roughly 17% of potential value, demonstrating that Sirona Dental operates almost exclusively through a single DLA IDIQ vehicle. The top two parent vehicles are both DLA IDIQs: SPE2DH20D0048 (12,195 task orders, $43.9 million combined potential value) and SPE2DE15D0020 (4,112 task orders, $32.7 million combined potential value). These vehicles have been active since September 2020 through September 2025, with the source indicating approximately $5.5 million in cumulative delivery orders executed as of early 2024—a fraction of the current portfolio, suggesting accelerating utilization or data capture of historical awards in recent years.

Activity across Sirona Dental shows 2,506 awards in 2024 and 2,078 in 2025, trending consistent with prior years (2,481 and 2,543 in 2022 and 2023 respectively). The most recent award is dated February 25, 2026, indicating continued active procurement. The company has been registered in SAM.gov since 2013. Sirona Dental operates exclusively as a wholesaler and manufacturer supplier—no subcontract relationships appear in the federal award data; all 16,640 awards are prime vehicle delivery orders. The portfolio is heavily concentrated in PSC 4210 (Hospital Furniture, Equipment, Utensils, and Supplies: 11,561 awards) and PSC 6515 (Laboratory Equipment and Supplies: 3,902 awards), with smaller shares in Medical and Surgical Instruments (918 awards) and Dental Instruments and Equipment (159 awards), reflecting the product-line mix spanning hospital consumables and specialized dental diagnostics and manufacturing equipment.

As a child entity, Sirona Dental holds no prime contracting authority and depends entirely on parent-company primes and delivery-order volume through DLA for federal revenue. The subsidiary's role is purely as a supply-chain extension for Dentsply Sirona Inc.'s federal dental business—a high-volume, low-margin transactional position anchored to one customer and two IDIQ vehicles that expire or require recompete in September 2025 and beyond. For competitors or teaming partners, Sirona Dental signals strong integration with the DLA Medical Supply Chain and no independent pursuit capability or set-aside positioning.